443 related articles for article (PubMed ID: 32830215)
1. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure).
Richards M; Di Somma S; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Clopton P; Filippatos GS; Anand I; Ng L; Daniels LB; Neath SX; Shah K; Christenson R; Hartmann O; Anker SD; Maisel A
JACC Heart Fail; 2013 Jun; 1(3):192-9. PubMed ID: 24621869
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
Börschel CS; Ohlrogge AH; Geelhoed B; Niiranen T; Havulinna AS; Palosaari T; Jousilahti P; Rienstra M; van der Harst P; Blankenberg S; Zeller T; Salomaa V; Schnabel RB
Europace; 2021 May; 23(5):674-681. PubMed ID: 33458771
[TBL] [Abstract][Full Text] [Related]
5. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
6. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
[No Abstract] [Full Text] [Related]
8. Genome-Wide Association Study Implicates Atrial Natriuretic Peptide Rather Than B-Type Natriuretic Peptide in the Regulation of Blood Pressure in the General Population.
Salo PP; Havulinna AS; Tukiainen T; Raitakari O; Lehtimäki T; Kähönen M; Kettunen J; Männikkö M; Eriksson JG; Jula A; Blankenberg S; Zeller T; Salomaa V; Kristiansson K; Perola M
Circ Cardiovasc Genet; 2017 Dec; 10(6):e001713. PubMed ID: 29237677
[TBL] [Abstract][Full Text] [Related]
9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation.
Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y
Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499
[TBL] [Abstract][Full Text] [Related]
12. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
[TBL] [Abstract][Full Text] [Related]
13. The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
Kube J; Ebner N; Jankowska EA; Rozentryt P; Cicoira M; Filippatos GS; Ponikowski P; Doehner W; Anker SD; von Haehling S
Int J Cardiol; 2016 Sep; 219():84-91. PubMed ID: 27288971
[TBL] [Abstract][Full Text] [Related]
14. Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death.
Brady PF; Chua W; Nehaj F; Connolly DL; Khashaba A; Purmah YJV; Ul-Qamar MJ; Thomas MR; Varma C; Schnabel RB; Zeller T; Fabritz L; Kirchhof PF
J Am Heart Assoc; 2022 Feb; 11(4):e022833. PubMed ID: 35112889
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptides in heart failure and acute coronary syndrome.
Gaggin HK; Januzzi JL
Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
[TBL] [Abstract][Full Text] [Related]
17. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
18. A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
Jonmundsson T; Steindorsdottir AE; Austin TR; Frick EA; Axelsson GT; Launer L; Psaty BM; Loureiro J; Orth AP; Aspelund T; Emilsson V; Floyd JS; Jennings L; Gudnason V; Gudmundsdottir V
Europace; 2023 Nov; 25(11):. PubMed ID: 37967346
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
[TBL] [Abstract][Full Text] [Related]
20. Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients.
Nasab Mehrabi E; Toupchi-Khosroshahi V; Athari SS
ESC Heart Fail; 2023 Dec; 10(6):3250-3257. PubMed ID: 37776150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
